ANEB logo

Anebulo Pharmaceuticals (ANEB) Company Overview

Profile

Full Name:

Anebulo Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 7, 2021

Indexes:

Not included

Description:

Anebulo Pharmaceuticals focuses on developing innovative treatments for addiction and related disorders. Their main goal is to create effective therapies that can help people overcome substance use issues, improving overall health and well-being. The company aims to address significant unmet medical needs in this area.

Events Calendar

Earnings

Next earnings date:

Feb 13, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Sep 25, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 19, 24 Benchmark
Speculative Buy
Oct 1, 24 Benchmark
Speculative Buy
Oct 3, 23 Benchmark
Speculative Buy
Sep 25, 23 HC Wainwright & Co.
Buy
Sep 21, 23 Maxim Group
Buy
Sep 18, 23 HC Wainwright & Co.
Buy
May 18, 23 Benchmark
Speculative Buy
Feb 14, 23 Benchmark
Speculative Buy
Jul 27, 22 Ladenburg Thalmann
Buy
May 25, 21 Benchmark
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Are Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year?
Are Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year?
Are Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year?
ANEB
Zacks Investment ResearchOctober 19, 2023

Here is how Anebulo Pharmaceuticals, Inc. (ANEB) and Conmed (CNMD) have performed compared to their sector so far this year.

Anebulo (ANEB) Gains on Positive FDA Response for ANEB-001
Anebulo (ANEB) Gains on Positive FDA Response for ANEB-001
Anebulo (ANEB) Gains on Positive FDA Response for ANEB-001
ANEB
Zacks Investment ResearchAugust 22, 2023

Anebulo (ANEB) gains on positive FDA response for the phase III development of its lead candidate ANEB-001 for treating patients with acute cannabinoid intoxication.

Is Anebulo Pharmaceuticals (ANEB) Outperforming Other Medical Stocks This Year?
Is Anebulo Pharmaceuticals (ANEB) Outperforming Other Medical Stocks This Year?
Is Anebulo Pharmaceuticals (ANEB) Outperforming Other Medical Stocks This Year?
ANEB
Zacks Investment ResearchJune 12, 2023

Here is how Anebulo Pharmaceuticals, Inc. (ANEB) and Aquestive Therapeutics (AQST) have performed compared to their sector so far this year.

Has Anebulo Pharmaceuticals (ANEB) Outpaced Other Medical Stocks This Year?
Has Anebulo Pharmaceuticals (ANEB) Outpaced Other Medical Stocks This Year?
Has Anebulo Pharmaceuticals (ANEB) Outpaced Other Medical Stocks This Year?
ANEB
Zacks Investment ResearchMay 24, 2023

Here is how Anebulo Pharmaceuticals, Inc. (ANEB) and Ligand Pharmaceuticals (LGND) have performed compared to their sector so far this year.

FAQ

  • What is the ticker symbol for Anebulo Pharmaceuticals?
  • Does Anebulo Pharmaceuticals pay dividends?
  • What sector is Anebulo Pharmaceuticals in?
  • What industry is Anebulo Pharmaceuticals in?
  • What country is Anebulo Pharmaceuticals based in?
  • When did Anebulo Pharmaceuticals go public?
  • Is Anebulo Pharmaceuticals in the S&P 500?
  • Is Anebulo Pharmaceuticals in the NASDAQ 100?
  • Is Anebulo Pharmaceuticals in the Dow Jones?
  • When was Anebulo Pharmaceuticals's last earnings report?
  • When does Anebulo Pharmaceuticals report earnings?
  • Should I buy Anebulo Pharmaceuticals stock now?

What is the ticker symbol for Anebulo Pharmaceuticals?

The ticker symbol for Anebulo Pharmaceuticals is NASDAQ:ANEB

Does Anebulo Pharmaceuticals pay dividends?

No, Anebulo Pharmaceuticals does not pay dividends

What sector is Anebulo Pharmaceuticals in?

Anebulo Pharmaceuticals is in the Healthcare sector

What industry is Anebulo Pharmaceuticals in?

Anebulo Pharmaceuticals is in the Biotechnology industry

What country is Anebulo Pharmaceuticals based in?

Anebulo Pharmaceuticals is headquartered in United States

When did Anebulo Pharmaceuticals go public?

Anebulo Pharmaceuticals's initial public offering (IPO) was on May 7, 2021

Is Anebulo Pharmaceuticals in the S&P 500?

No, Anebulo Pharmaceuticals is not included in the S&P 500 index

Is Anebulo Pharmaceuticals in the NASDAQ 100?

No, Anebulo Pharmaceuticals is not included in the NASDAQ 100 index

Is Anebulo Pharmaceuticals in the Dow Jones?

No, Anebulo Pharmaceuticals is not included in the Dow Jones index

When was Anebulo Pharmaceuticals's last earnings report?

Anebulo Pharmaceuticals's most recent earnings report was on Nov 13, 2024

When does Anebulo Pharmaceuticals report earnings?

The next expected earnings date for Anebulo Pharmaceuticals is Feb 13, 2025

Should I buy Anebulo Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions